Lascufloxacin
Tier C — Watch / tradeLascufloxacin
Targets：Topoisomerase IV、Bacterial DNA gyrase
Brand：Lasvic
Indications (approved)：耳鼻咽喉疾病、肺炎、呼吸道感染
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LASC-001 | 635319-09-4 | tert-butyl (3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate |
| LASC-002 | 848416-47-7 | tert-butyl (3S,4R)-3-(bromomethyl)-4-hydroxypyrrolidine-1-carboxylate |
| LASC-003 | 848416-48-8 | tert-butyl (3S,4S)-3-(bromomethyl)-4-fluoropyrrolidine-1-carboxylate |
| LASC-004 | 848416-49-9 | tert-butyl (3S,4S)-3-((cyclopropylamino)methyl)-4-fluoropyrrolidine-1-carboxylate |
| LASC-005 | 604798-54-1 | N-(((3R,4S)-4-fluoropyrrolidin-3-yl)methyl)cyclopropanamine |
| LASC-006 | 848498-67-9 | 8,9-difluoro-6-(2-fluoroethyl)-7-methoxy-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate |
Frequently asked questions
What are the approved indications of Lascufloxacin?
Approved indications include: 耳鼻咽喉疾病, 肺炎, 呼吸道感染.
When does the Lascufloxacin patent expire?
No public expiry year is available for Lascufloxacin yet; this page updates once verified.
How many synthesis routes are recorded for Lascufloxacin?
1 synthesis routes are recorded; the shortest is 5 steps with 9.57 kg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Lascufloxacin intermediates?
All intermediates in Lascufloxacin routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Lascufloxacin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24